Alkeon Capital Management’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,743,505
| Closed | -$14.1M | – | 82 |
|
|
2024
Q1 | $14.1M | Sell |
2,743,505
-370,059
| -12% | -$1.9M | 0.02% | 65 |
|
|
2023
Q4 | $17.8M | Buy |
3,113,564
+1,468,701
| +89% | +$8.42M | 0.04% | 66 |
|
|
2023
Q3 | $7.86M | Buy |
1,644,863
+287,800
| +21% | +$1.38M | 0.01% | 77 |
|
|
2023
Q2 | $5.77M | Buy |
1,357,063
+302,418
| +29% | +$1.29M | 0.01% | 87 |
|
|
2023
Q1 | $5.6M | Sell |
1,054,645
-3,958
| -0.4% | -$21K | 0.01% | 92 |
|
|
2022
Q4 | $6.65M | Sell |
1,058,603
-163,488
| -13% | -$1.03M | 0.03% | 93 |
|
|
2022
Q3 | $12.9M | Buy |
1,222,091
+348,542
| +40% | +$3.68M | 0.04% | 91 |
|
|
2022
Q2 | $4.74M | Sell |
873,549
-350,000
| -29% | -$1.9M | 0.01% | 104 |
|
|
2022
Q1 | $11.2M | Sell |
1,223,549
-23,076
| -2% | -$212K | 0.02% | 101 |
|
|
2021
Q4 | $18.8M | Hold |
1,246,625
| – | – | 0.03% | 109 |
|
|
2021
Q3 | $29.8M | Buy |
+1,246,625
| New | +$29.8M | 0.05% | 105 |
|